Form 4: Underberg Sharon E. sold IDXX
Underberg Sharon E. (EVP, GC & Corporate Secretary at IDEXX LABORATORIES INC /DE) reported an open-market sale of 8,906 shares of IDXX at an average $688.59, roughly $6,132,605, in a Form 4 filed 2026-11-05.
Past performance does not predict future results. Informational only, not investment advice.
Underberg Sharon E. (EVP, GC & Corporate Secretary at IDEXX LABORATORIES INC /DE) reported an open-market sale of 8,906 shares of IDXX at an average $688.59, roughly $6,132,605, in a Form 4 filed 2026-11-05.
MAZELSKY JONATHAN JAY (Executive Chair of the Board at IDEXX LABORATORIES INC /DE) reported an open-market sale of 25,140 shares of IDXX at an average $703.19, roughly $17,678,195, in a Form 4 filed 2026-11-05.
Lane Michael (Executive Vice President at IDEXX LABORATORIES INC /DE) reported an open-market sale of 3,978.94 shares of IDXX at an average $688.64, roughly $2,740,069, in a Form 4 filed 2026-11-05.
JUNIUS DANIEL M (Director at IDEXX LABORATORIES INC /DE) reported an open-market sale of 1,200 shares of IDXX at an average $704.07, roughly $844,888, in a Form 4 filed 2026-11-05.
Kingsley Lawrence D (Director at IDEXX LABORATORIES INC /DE) reported an open-market sale of 2,203 shares of IDXX at an average $532.08, roughly $1,172,178, in a Form 4 filed 2026-09-09.
End of results.